2m 2m 2m 2m 2m 2m 2m
COMPASS THERAPTC (CMPX)
NASDAQ
$1.93+$0.02 (+1.05%)
Price as of Aug 03, 2026 7:26 AM EDT- $344.0MMarket Cap
- -35.25%1-Year Change
- BiotechnologyIndustry
COMPASS THERAPTC (CMPX)
$1.93+$0.02 (+1.05%)
CMPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.91 | ||
Change | -$0.03 (-1.55%) | ||
Open | $1.95 | ||
High | $1.96 | ||
Low | $1.86 | ||
Previous Close | $1.94 | ||
Volume | 2,640,537 | ||
30-Day Average Volume | 2,389,332 | ||
1-Week Change | -7.73% | ||
1-Month Change | -12.79% | ||
1-Year Change | -35.25% | ||
3-Year Change | -33.45% | ||
5-Year Change | -77.15% | ||
Fundamentals | |||
Shares Outstanding | 180.1M | ||
Total Assets | $205.2M | ||
Market Cap | $344.0M | ||
Enterprise Value | $288.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.3M | ||
Free Cash Flow | -$17.4M | ||
EBIT | -$18.3M | ||
EBITDA | -$18.3M | ||
Net Working Capital | $185.4M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -19 | ||
PEG | 1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue